d-Dimer elevation and adverse outcomes

[1]  G. Lip,et al.  d-Dimer elevation and adverse outcomes The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters , 2015 .

[2]  A. Mebazaa,et al.  D‐dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial , 2014, Journal of thrombosis and haemostasis : JTH.

[3]  A. Exadaktylos,et al.  D-dimer to rule out pulmonary embolism in renal insufficiency. , 2014, The American journal of medicine.

[4]  Yanyan Li,et al.  Prognostic role of D-dimer in patients with lung cancer: a meta-analysis , 2014, Tumor Biology.

[5]  S. Costanzo,et al.  Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study , 2013, Haematologica.

[6]  Xian-liang Zhou,et al.  Value of D-dimer and C reactive protein in predicting inhospital death in acute aortic dissection , 2013, Heart.

[7]  Xiang Xue,et al.  Evaluation of Risk Factors for Venous Thromboembolism in Chinese Women With Epithelial Ovarian Cancer , 2013, International Journal of Gynecologic Cancer.

[8]  F. Jaimes,et al.  D-dimer is a significant prognostic factor in patients with suspected infection and sepsis. , 2012, The American journal of emergency medicine.

[9]  F. Guadagni,et al.  Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients. , 2012, Clinical lung cancer.

[10]  Zhen Zhou,et al.  Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients , 2012, Journal of surgical oncology.

[11]  O. Wagner,et al.  High D-dimer levels are associated with poor prognosis in cancer patients , 2012, Haematologica.

[12]  D. Angiolillo,et al.  Antithrombotic Therapy in Patients With Chronic Kidney Disease , 2012, Circulation.

[13]  Zhao Han,et al.  The incidence of venous thromboembolism following stroke and its risk factors in eastern China , 2012, Journal of Thrombosis and Thrombolysis.

[14]  M. Yılmaz,et al.  Increased d-dimer levels predict cardiovascular mortality in patients with systolic heart failure , 2012, Journal of Thrombosis and Thrombolysis.

[15]  Xiaoying Li,et al.  Measurement of D-dimer as aid in risk evaluation of VTE in elderly patients hospitalized for acute illness: a prospective, multicenter study in China. , 2011, Clinical and investigative medicine. Medecine clinique et experimentale.

[16]  G. Agnelli,et al.  D-Dimer for risk stratification in patients with acute pulmonary embolism , 2011, Journal of Thrombosis and Thrombolysis.

[17]  J. Douketis,et al.  Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability of d-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism , 2010, Annals of Internal Medicine.

[18]  A. Hongo,et al.  D-dimer level as a risk factor for postoperative venous thromboembolism in Japanese women with gynecologic cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  P. Rose,et al.  Elevated D-dimers are also a marker of underlying malignancy and increased mortality in the absence of venous thromboembolism , 2010, Journal of Clinical Pathology.

[20]  H. Büller,et al.  Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts , 2010, BMJ : British Medical Journal.

[21]  A. Khorana,et al.  Cancer, clots and consensus: new understanding of an old problem. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  O. Wagner,et al.  D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  C. Cimminiello,et al.  D-dimer before chemotherapy might predict venous thromboembolism , 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[24]  Soheir S Adam,et al.  D-dimer antigen: current concepts and future prospects. , 2009, Blood.

[25]  J. Frøkjær,et al.  Preoperative Plasma D-Dimer Is a Predictor of Postoperative Deep Venous Thrombosis in Colorectal Cancer Patients: A Clinical, Prospective Cohort Study with One-Year Follow-Up , 2009, Diseases of the colon and rectum.

[26]  J. Douketis,et al.  Systematic Review: d-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism , 2008, Annals of Internal Medicine.

[27]  H J Rupprecht,et al.  Haemostatic Factors and the Risk of Cardiovascular Death in Patients With Coronary Artery Disease: The AtheroGene Study , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[28]  J. Cornuz,et al.  Prognostic value of D-dimer in patients with pulmonary embolism , 2006, Thrombosis and Haemostasis.

[29]  W. Ageno,et al.  D-dimer is not a long-term prognostic marker following acute cerebral ischemia , 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[30]  O. Morel,et al.  Diagnostic and prognostic value of circulating D-Dimers in patients with acute aortic dissection , 2006, Critical care medicine.

[31]  S. Doucette,et al.  Does this patient have deep vein thrombosis? , 1998, JAMA.

[32]  A. Kızıltunç,et al.  Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease. , 2006, Thrombosis research.

[33]  E. E. van der Wall,et al.  Risks of oral anticoagulant therapy with increasing age. , 2005, Archives of internal medicine.

[34]  J. M. Tenías,et al.  Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia. , 2004, Chest.

[35]  A. Turpie,et al.  Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study. , 2004, Archives of pathology & laboratory medicine.

[36]  A. Yinnon,et al.  A rapid quantitative D-dimer assay at admission correlates with the severity of community acquired pneumonia , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[37]  O. Wagner,et al.  D-dimer levels and risk of recurrent venous thromboembolism. , 2003, JAMA.

[38]  F. Bernardi,et al.  Predictive Value of D‐Dimer Test for Recurrent Venous Thromboembolism After Anticoagulation Withdrawal in Subjects With a Previous Idiopathic Event and in Carriers of Congenital Thrombophilia , 2003, Circulation.

[39]  A. Folsom,et al.  Fibrin fragment D-dimer and the risk of future venous thrombosis. , 2003, Blood.

[40]  B. Psaty,et al.  Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency , 2003, Circulation.

[41]  M. Di Napoli,et al.  Inflammation, Hemostatic Markers, and Antithrombotic Agents in Relation to Long-Term Risk of New Cardiovascular Events in First-Ever Ischemic Stroke Patients , 2002, Stroke.

[42]  T. Spector,et al.  Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state , 2002, The Lancet.

[43]  B. Cosmi,et al.  Risk of Venous Thromboembolism Recurrence: High Negative Predictive Value of D-dimer Performed after Oral Anticoagulation Is Stopped , 2002, Thrombosis and Haemostasis.

[44]  G. Kovacs,et al.  Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical Model and d-dimer , 2001, Annals of Internal Medicine.

[45]  H. Bounameaux,et al.  Effects of age on the performance of common diagnostic tests for pulmonary embolism. , 2000, The American journal of medicine.

[46]  W M O'Fallon,et al.  Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. , 2000, Archives of internal medicine.

[47]  F. Rosendaal.  Venous thrombosis: a multicausal disease , 1999, The Lancet.

[48]  G. Hanzel,et al.  D-dimer assay predicts mortality in critically ill patients without disseminated intravascular coagulation or venous thromboembolic disease , 1999, Intensive Care Medicine.

[49]  M. Kollef,et al.  A rapid assay for the detection of circulating D-dimer is associated with clinical outcomes among critically ill patients. , 1998, Critical care medicine.

[50]  G. Lip,et al.  Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. , 1996, Circulation.

[51]  W. Feinberg,et al.  Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome. , 1996, Stroke.

[52]  H. Tohgi,et al.  Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism. , 1990, Stroke.